Wuxi, China · Founded 1999 · Privately Held (backing)
Developer and manufacturer of pharmaceutical drugs with clinical value intended to specialize in the area of dermatology and nephrology. Sinomune Pharmaceutical is based in Wuxi, China and was founded in 1999. Its last reported valuation was $300 million in Aug 2021. It has raised $64.4 million.
Last reported valuation
$300.5M
Oct 2026
Priced at
—
Total raised
$64.4M
Last round
—
Cap table — not yet on record
Sinomune Pharmaceutical's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sinomune Pharmaceutical with a free account
·Watch Sinomune Pharmaceutical: the Monday email on marks, rounds and moves
